e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Basic research on lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance
C. Wohlkoenig, K. Leithner, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria)
Source:
Annual Congress 2013 –Basic research on lung cancer
Session:
Basic research on lung cancer
Session type:
Poster Discussion
Number:
3109
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Wohlkoenig, K. Leithner, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria). Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance. Eur Respir J 2013; 42: Suppl. 57, 3109
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
The role of HIF-1 pathway in non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
EGFR mutations determine EGFR-MET crosstalk and MET inhibition in lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
The roles of Ki-67, p53, transforming growth factor- and lysyl oxidase in the metastasis of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Role of insulin and IGF-1 receptors in bronchial epithelial cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
A role for cAMP-responsive element binding protein in lung adenocarcinoma
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept